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Transtorming growth fac to r4  (TGF-a) i s  an autocrine growth factor for epidernial 
keratinocytes that can induce its own expression (autoinduction). Because the 
regulation of this process may be important tor the control of epidermal growth, 
we examined the roles of EGF receptor tyrosine kinase and protein kinase C (PKC) 
in TGF-a autoinduction in cultured human keratinocytes. Antiphosphotyrosine 
immunoblot analysis demonstrated that EGF and TGF-a rapidly and markedly 
stimulated tyrosine phosphorylation of a 170 kDa protein in growth factor-dc- 
prived keratinocytes. This protein was identified as the EGF receptor by immuno- 
precipitation using anti-EGF receptor mAbs. Tyrosine phosphorylation and TGF-a 
mRNA accumulation in response to EGF and TGF-a were both inhibited by a 
monoclonal antibody against the EGF receptor and by the EGF receptor tyrosine 
kinase inhibitor RC50864, demonstrating the involvement of the tyrosine kinase 
activity of the receptor in TGF-a autoinduction. The monoclonal antibody inhib- 
ited keratinocyte growth and TGF-a autoinduction with similar potency 
(IC5" -- 0.1 pgiml). 1-GF-a and the PKC activator tetradecanoyl phorbol 12-myris- 
tyl, 13-acetate (TPA) had similar effects on TGF-a steady-state mRNA levels, 
suggesting that F'KC activation might be a downstream mediator of TGF-a autoin- 
duction. However, down-regulation of more than 90% of keratinocyte PKC activ- 
ity by bryostatin pretreatment abrogated the induction of TGF-a mRNA in re- 
sponse to TPA without affecting the autoinductive reqonse or EGF-stimulated 
tyrosine phosphorylation. These results indicate that EGF receptor and PKC stimu- 
late TGF-a gene expression by different pathways, and suggest that PKC is riot 
required for TGF-a autoinduction in this system. Moreover, the fact that ECF- 
stimulated tyrosine phosphorylation and TGF-a autoinduction were not potenti- 
ated after PKC down-regulation suggests that PKC does not exert a tonic inhibitory 
influence on EGF receptor tyrosine kinasc activity in normal hunian keratinocytes. 
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The growth factor receptor-associated tyrosine ki- 
nases mediate the pleiotypic effects of their ligands, 
including cell proliferation (Hanks et al., 1988). Trans- 
Section studies have demonstrated that the tyrosine ki- 
nase activity of the epidermal growth factor (EGF) re- 
ceptor mediates the pleiotypic response t o  EGF in 
fibroblasts and hematopoietic cells (Honegger et al., 
1987; Chen et al., 1987; Pierce et al., 1988). However, 
transforming growth factor-a (TGF-a), and not EGF, 
appears to be the cognate EGF receptor ligand produced 
in an autocrine fashion in a variety of epithelial tissues 
(Koyama and Podolsky, 1989; Cartlidge and Elder, 
1989; Malden et al., 1989; Mead and Fausto, 1989; 
Markowitz et al., 1990). TGF-a binds to the EGF recep- 
tor with high affinity (Massague, 1983; Derynck et al., 
1984), and overexpression of TGF-cr in transgenic mice 
results in epithelial hyperplasia in several epithelial 
tissues (Matsui et al., 1990; Jhappan et al., 1990; 
Sandgren et al., 1990). TGF-a is markedly overex- 
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pressed in the skin lesions of psoriasis, an  inflamma- 
tory and hyperplastic skin disease (Gottlieb et al., 1988; 
Elder et al., 1989a; Higashiyama et  al., 1991). Recently, 
targeted overexpression of TGF-a in murine epidermis 
has been shown to cause epidermal hyperplasia and 
scaling similar to that seen in psoriatic lesions (Vassar 
and Fuchs, 1991). TGF-a and EGF both stimulate 
TGF-a expression (autoinduction) in murine and hu- 
man keratinocytes (Coffey et al., 1987, 1988). Since 
TGF-a is potently mitogenic for keratinocytes (Coffey 
et al., 1987; Barrandon and Green, 1987; Elder et al., 
1989b), increased EGF receptor tyrosine kinase activ- 
ity could explain both the hyperplasia and the overex- 
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pression of TGF-a which occur in psoriasis. In fact. in- 
creased EGF-dependent tyrosine kinase activity has 
been observed in psoriatic lesions (Gentleman et al., 
1984). 
One candidate for altered regulation of EGF receptor 
tyrosine kinase activity in psoriasis is protein kinase C 
(PKC). PKC has been reported to inhibit EGF receptor 
tyrosine kinase activity via phosphorylation of a threo- 
nine residue at position 654 of the receptor (Friedman 
et al., 1984; Davis, 1988; Livneh et al., 1988; Decker et 
al., 1990). Thus, PKC may normally act as a negative 
regulator of EGF receptor activation. PKC activity is 
significantly reduced in psoriatic epidermis (Horn et 
al., 1987). By this concept, reduced PKC activity in 
psoriasis would potentiate keratinocyte responses to 
EGF receptor activation, including proliferation and 
expression of the EGF receptor agonist, TGF-a. 
Alternatively, i t  is also possible that activation, 
rather than down-regulation, of PKC is responsible for 
increased TGF-a expression in psoriasis. Diacylglyc- 
erol (DAG) and tetradecanoyl phorbol acetate (TPA), 
two agents which activate PKC, stimulate keratinocyte 
production of TGF-a mRNA and protein (Pittelkow et 
al., 1989). Moreover, several lines of evidence suggest 
that chronic PKC activation occurs in psoriasis. Phos- 
pholipase C (PLC) activity is markedly increased in 
psoriatic lesions (Bartel et al., 1987; Bergers et al., 
1990; Fisher et al., 19901, as is the content of its prod- 
uct, the PKC activator diacylglycerol (Fisher et al., 
1990). It has been suggested that down-regulation of 
PKC in response to chronic activation could explain the 
reduced PKC levels characteristic of psoriatic epider- 
mis (Fisher et al., 1990). 
One possible stimulus for PKC activation in psoriasis 
is TGF-cr itself. Ligand binding results in tyrosine phos- 
phorylation and activation of phospholipase C-gamma 
(PLC-gamma) by EGF receptor tyrosine kinase in A431 
cells (Wahl et al., 1988; Margolis et al., 1989; Nishibe et 
al., 1990). Consistent with this model, EGF was found 
to activate phosphoinositide turnover and stimulate 
phosphorylation of the PKC-specific substrate p80 in 
the immortalized murine keratinocyte line, BalbiMK 
(Moscat et al., 1988). These results, coupled with the 
observation that direct activators of PKC are known to 
stimulate expression of TGF-a (Pittelkow et al., 19891, 
suggest that PKC might be a distal component of the 
signal transduction pathway mediating TGF-a autoin- 
duction, and other cellular responses to TGF-a as  well. 
In order to address these interrelated issues, we have 
determined whether TGF-a autoinduction requires ac- 
tivation of the EGF receptor tyrosine kinase in human 
keratinocytes, and whether PKC activation is involved 
in this process as  a postreceptor event. In addition, in 
order to determine whether PKC actually acts as a 
negative regulator of the EGF receptor tyrosine kinase 
in intact epidermal cells, we have determined whether 
experimental reduction in PKC activity can potentiate 
EGF receptor tyrosine kinase activation and autoin- 
duction of TGF-a in human keratinocytes. 
MATERIALS AND METHODS 
Reagents 
Bryostatin 1 was generously provided by Dr. G. Petit, 
University of Arizona, and the tyrphostins RG 50864 
and 50862 were kindly supplied by Rorer Biotechnol- 
ogy, King of Prussia, PA. Recombinant human TGF-a 
was provided by Dr. R. Derynck, Genentech, Inc., South 
San Francisco, CA, or purchased from Collaborative 
Research. TGF-p1 from bovine bone was the kind gift of 
Dr. L. Ellingsworth, Collagen Corp., Palo Alto, CA. 
Preparation and characterization of the anti-EGF re- 
ceptor monoclonal antibody 225 IgG has been described 
(Kawamoto et al., 1983; Gill et al., 1984; Sunada et al., 
1986). 
TPA and the monoclonal antibody MOPC 21 were 
from Sigma, and bovine insulin bovine pituitary ex- 
tract and murine submaxillary gland epidermal growth 
factor were from Clonetics. Recombinant human cyto- 
kines IL-6 and GM-CSF were purchased from Amgen, 
IL-2, PDGF, and IFN-gamma from Collaborative Re- 
search, and IL-la from Dainippon. All other biochemi- 
cals were of reagent grade. 
Keratinocyte culture 
Cultured adult human keratinocytes were propa- 
gated from keratome biopsies of human skin as  de- 
scribed (Tsao et al., 1982; Wille et al., 19841, using a 
commercially available modification of MCDB 153 me- 
dium optimized for high density keratinocyte growth 
(Keratinocyte Growth Medium, Clonetics). Secondary 
cultures in the second to fourth passage were deprived 
of polypeptide growth factors at 40 to 50% confluence 
by incubation in MCDB 153 or Keratinocyte Basal Me- 
dium (Clonetics) for 48 hours prior to agonist treatment 
as described (Coffey et al., 1987). During this period, 
cell confluence increased to SO to 90%. For analysis of 
TGF-a mRNA levels, cells were treated with natural 
murine EGF (Clonetics) or human recombinant TGF-cr 
(Collaborative Research) a t  various doses for various 
times as described in the figure legends. Unless other- 
wise specified, the standard stimulation with either 
agent was 4 hours of treatment with 20 nglml EGF or 
Clonal growth assays were performed as described 
(Tsao et al., 1982; Wille et al., 1984) except that Kerati- 
nocyte Basal Medium (Clonetics) was used instead of 
MCDB 153 and cells were plated at 2,000 rather than 
400 cells per 60 mm dish. 
RNA extraction and analysis 
RNA was isolated by guanidinium isothionate with 
(Chomczynski and Sacchi, 1987) or without acid phenol 
extraction as described (Nickoloff et al., 1989). Methods 
for blot hybridization and washing, probe preparation 
and labelling, and laser densitometry methods have 
been described (Elder et al., 1990). Briefly, 20 pg total 
RNA was separated by electrophoresis in 1% agarose 
gels, transferred to derivatized nylon membranes 
(Zeta-Probe, Bio-Rad, Richmond, CA), and hybridized 
for 18-24 hours against 1 x lo6 cpmiml random- 
primed probe in 50% formamide, 5X SSC, 50 mM so- 
dium phosphate (pH 7.0), 1X Denhardt’s solution, 250 
p.glml yeast tRNA, 100 pgiml denatured sonicated 
salmon sperm DNA, and 1% SDS. After autoradiogra- 
phy a t  -70°C using intensifying screens, band intensi- 
ties were quantitated by laser densitometry using an  
LKB model 2202 densitometer coupled t o  a Hewlet- 
Packard 3390A integrator. Only bands which fell in the 
TGF-a. 
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linear range of densitometric responsiveness, as deter- 
mined by loading different amounts of input RNA, were 
used. Unless otherwise indicated, data which have been 
quantitated by densitometry are normalized to the ref- 
erence gene, cyclophilin, and expressed as fold-change 
relative to control untreated samples as described (El- 
der et al., 1990). 
Protein kinase C assay 
Total cellular PKC activity was measured in cul- 
tured keratinocytes deprived of growth factors for 30 
hours, and bryostatin or DMSO vehicle was added for 
an  additional 18 hours. Cells were harvested by scrap- 
ing on ice in 20 mM Tris-HCI (pH 7 3 ,  5 mM EGTA, 2 
mM EDTA, 10 mM P-mercaptoethanol, and 0.01% leu- 
peptin, and disrupted by sonication. Total cellular PKC 
was extracted by addition of 1% Triton X-100 and par- 
tially purified by ion exchange chromatography (Kik- 
kawa et al., 1982). Total PKC activity was determined 
by subtracting the histone phosphorylation obtained in 
the absence of calcium, phosphatidylserine, and TPA 
from that obtained in their presence (Fisher et al., 
1987). 
Western blot assay for tyrosine phosphorylation 
Keratinocytes grown in 100 mm dishes were depleted 
of growth factors for 48 hours and treated with various 
doses of EGF or TGF-(r as described above. After vari- 
ous periods of time (usually 5 minutes), cells were lysed 
for determination of tyrosine phosphorylation essen- 
tially as  described (Honegger et al., 1990). Cells were 
rapidly placed on ice and washed once with ice-cold 
Dulbecco's phosphate buffered saline (PBS) without 
calcium and magnesium (Gibco) containing 10 pM so- 
dium orthovanadate, then scraped into 500 ~1 lysis 
buffer containing 50 mM HEPES, 150 mM NaC1,l mM 
EGTA, 1.5 mM MgCI,, 10% glycerol, 1% Triton X-100, 
100 mM NaF, 10 mM sodium pyrophosphate, 200 pM 
sodium orthovanadate, 30 mM p-nitrophenyl phos- 
phate, 4 pgiml phenylmethylsulfonyl fluoride, 10 
pgiml leupeptin, and 10 pgiml aprotinin. Lysates were 
passed three times through a sterile 21G needle and 
spun in a microfuge at 4°C for 5 minutes. Supernatants 
were either stored a t  -20°C for up to one week or  ana- 
lyzed directly. Forty t o  100 kg protein (as determined 
by the Bradford dye-binding assay, Bio-Rad, Richmond, 
CA) were subjected to SDS-PAGE using precast gels 
(Novexi according to the manufacturer's instructions. 
Samples were transferred to 0.22 p nitrocellulose 
sheets using a semi-dry blotting apparatus (Bio-Rad) 
according to manufacturer's instructions. Filters were 
blocked in 5% nonfat dry milk in PBS containing 0.1% 
NaN, (blotto) for 1 to 4 hours a t  20°C or overnight at 
4"C, then incubated in the antiphosphotyrosine mAb 
PY20 (Oncogene Sciences) a t  2 pgiml in blotto over- 
night a t  4°C or  for 4 hours at 20°C. Filters were then 
washed 3 x 10 minutes a t  20°C in TBSiTween (10 mM 
Tris-HC1 (pH 7.41, 0.9% NaC1, 0.1% Tween-20), then 
incubated for 1 hour at 20°C in 4 pg/ml rabbit anti- 
mouse IgG (Cappell Research Products, Durham, NC) 
in blotto. After 3 x 10 minute washes in TBSiTween, 
filters were incubated in lZ5I staph A protein (10 pCii 
ml, >30 pCi/p.g, ICN, Costa Mesa, CA) in blotto, 
TABLE 1. Ligand specificity of TGF-a induction' 





















































'Quiescent keratinocytes were treated for 4 hours with the indicated concentrations 
of the agonists shown. 
2Abbreviations: bFGF, basic fibroblast growth factor; BPE, bovine pituitary extract: 
GM-CSF, colony stimulating factor (granulocyte-macrophage); IFN-gamma, inter- 
feron-gamma; IGF-I, insulinlikc growth factor-1; IJ,-le, interleukin 1-alpha; IL-2, 
interleukin-2; IL-6, interleukin 6 PDGF, platelet-derived growth factor; TGF-8, 
transforming growth factor-p. 
"Mean fold-induction relative to untreated quiescent keratinocytes, after normaliza- 
tion to cyclophilin. 
'995% confidence interval. 95% confidence intervals were calculated from the 
standard errors of the induction values. 
washed 3 x 10 minutes in blotto, dried briefly, and au- 
toradiographed using intensifying screens. 
Immunoprecipitation 
Keratinocytes in 100 mm dishes were treated with 
EGF (200 ngiml) for 5 minutes, washed with ice-cold 
Ca' ' , Mg ' +-free PBS containing 10 pM NaVO,, and 
lysed in 500 pl ice-cold RIPA buffer as described 
(Sunada et al., 1990). Immunoprecipitation was carried 
out by adding 2 pg of the anti-EGF receptor mAbs 528, 
225 (Sunada et al., 1986) or 05101 (UBI) to 250 pl of 
RIPA lysate for 30 minutes a t  room temperature fol- 
lowed by 5 pg of rabbit anti-mouse (RAM) IgG (Cappel) 
for 15 minutes. 50 pl of 10% Pansorbin was then added, 
and incubation continued an additional 30 minutes. 
After pelleting in a microfuge, the pellet was washed 
twice in 10 mM Hepes (pH 7.41, 0.5% Triton X-100, 5% 
glycerol as described (Sunada et  al., 1990). Electro- 
phoresis, blotting, and decoration with PY20 were as 
described above, except that the incubation with RAM 
IgG secondary antibody was omitted. 
RESULTS 
We assessed the specificity of TGF-a mRNA induc- 
tion in response to various polypeptides to investigate 
the involvement of the EGF receptor in the process of 
TGF-a autoinduction. Growth factor-deprived kerati- 
nocytes were stimulated €or 4 hours with a variety of 
growth factors and cytokines and induction of TGF-a 
transcripts was assessed by RNA blot hybridization. Of 
the 13 factors tested, only TGF-(r and EGF significantly 
induced TGF-a mRNA (Table 1). This ligand specificity 
strongly suggests that TGF-a autoinduction is medi- 
ated by the EGF receptor. In order to further substanti- 
ate this conclusion, we measured the effects of 225 IgG, 
a well-characterized anti-EGF receptor monoclonal an- 
tibody (Kawamoto et al., 1983; Gill et al., 1984; Sunada 
et al., 19861, on TGF-a autoinduction and EGF receptor 
tyrosine phosphorylation in keratinocytes. At 4"C, 225 
IgG competitively inhibits EGF and TGF-w. binding, 
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Fig. 1. Inhibition of TGF-a autoinduction by mAb 225 IgG. A Dose 
response of TGF-a autoinduction. Growth factor-depleted kerati- 
nocytes were incubated with the indicated concentrations of TGF-a for 
4 hours, followed by lysis and RNA blot analysis against TGF-u and 
tion to cyclophilin is shown below the autoradiogram. B: Autoinduc- 0 0 * 0 - * [225 'gGll pg'm' 
tion of TGF-w mRNA is inhibited by mAb 225 IgG. Growth factor- 
depleted keratinocytes were incubated with the indicated con- 
centrations of mAb 225 IgG for 30 minutes, followed by addition of 
TPA (20 nM), TGF-a (20 ngiml) or EGF (20 ng/ml). RNA was har- 
vested after 4 hours and analyzed by blot hybridization. Data are 
expressed as a percentage of the stimulation over baseline obtained for 
each agonist in the absence of 225 IgG. Data shown represent 
mean 2 SEM of three or more determinations. C: RNA blot hybridiza- 
tion of a representative experiment. C indicates no addition of agonist. 
C C  TGF-cx TPA agonist n m l o m  
cyclophilin probes. Fold-induction of TGF-rr mRNA after normaliza- l-brlqu-? u ? ? ?  
TG F-a 
cyclo 
while at 37"C, it causes EGFR internalization in intact 
cells but does not stimulate EGFR autophosphorylation 
(Sunada et al., 1986). 
Figure 1A demonstrates the dose response of TGF-o! 
mRNA accumulation in response to exogenous TGF-a 
in cultured keratinocytes (autoinduction). This re- 
sponse has previously been shown to correlate with the 
accumulation of TGF-a protein in the culture superna- 
tant under these conditions (Coffey et  al., 1987). Maxi- 
mal induction was obtained a t  a dose of 20 ng!ml 
TGF-a, and this dose was used for subsequent experi- 
ments. Pretreatment with 225 IgG for 30 minutes po- 
tently and markedly inhibited TGF-cu mRNA accumu- 
lation in response to both TGF-a and EGF. In contrast, 
the antibody did not inhibit accumulation of TGF-a 
mRNA accumulation in response to TPA (Fig. lB,C). 
As shown in Figure 2A, EGF and TGF-a rapidly 
stimulated tyrosine phosphorylation of a band of 
Mr - 170 kDa in growth factor-depleted human kera- 
tinocytes. Persistent phosphorylation of this band was 
noted in the continued presence of TGF-a agonist for up 
to 4 hours. The 170 kDa band was demonstrated to be 
the EGF receptor by co-migration with a band present 
in EGF-stimulated A431 control membranes (Fig. 2A- 
C), and by immunoprecipitation of a band of 170 kDa 
with three different anti-EGF receptor mAbs (Fig. 2Bj. 
As shown in Figure 2C, EGF-stimulated tyrosine phos- 
phorylation of the 170 kDa band was completely inhib- 
ited by 30 minutes preincubation with 5 pgiml of the 
anti-EGF receptor mAb 225 IgG, while the presence of 
the same concentration of the isotype control mAb 
MOPC 21 had no effect. As previously reported in A431 
cells (Sunada et al., 19861, treatment of keratinocytes 
with 225 IgG alone did not result in tyrosine phosphor- 
ylation of the 170 kDa band (Fig. 2B). 
As shown in Figure 3, mAb 225 IgG also inhibited 
clonal keratinocyte growth with a potency similar to its 
effects on autoinduction (ICG0 approximately 0.1 pgi 
mlj. The isotype control antibody, MOPC 21, was inac- 
tive in inhibiting clonal keratinocyte growth (data not 
shown j. 
To directly demonstrate a requirement for the ty- 
rosine kinase activity of the EGF receptor in kerati- 
nocyte TGF-o! autoinduction, we treated growth factor- 
depleted keratinocytes with the tyrphostin RG50864, a 
specific inhibitor of EGF receptor tyrosine kinase activ- 
ity (Lyall et al., 1989; Posner et al., 1989). As shown in 
Figure 4A, RG50864 inhibited EGF- and TGF-a-stimu- 
lated tyrosine phosphorylation in growth factor-de- 
pleted keratinocytes at 40 and 120 pM. The related 
tyrphostin, RG50862 (Lyall et al., 1989) was less active, 
inhibiting tyrosine phosphorylation a t  120 pM but not 
a t  40 pM. In some experiments, RG50864 alone demon- 
strated a partial agonist effect (Fig. 4A, left panel). As 
shown in Figure 4B and C, RG50864 displayed a dose- 
dependent inhibition of TGF-a mRNA accumulation in 
response to increasing amounts of exogenous TGF-a. 
Relatively high concentrations of RG50864 (>40 pM) 
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Fig. 2. Immunoblot analysis of tyrosine phosphorylation in intact 
human keratinocytes. A: Time course of EGF- and TGF-a-stimulated 
tyrosine phosphorylation. Growth factor-depleted keratinocytes were 
treated with EGF or TGF-a for the times indicated, then lysed as 
described in Materials and Methods. Gradient gels of 8-16’3 SDS- 
PAGE were loaded with 40 pg keratinocyte lysate protein per lane 
(approximately 2 x lo5 cell equivalents), immunoblotted, and deco- 
rated with PY20 antiphosphotyrosine mAb as described in Materials 
and Methods. Mobilities of molecular weight standards are indicated 
to the left. a, TGF-a, 20 ng/ml; E, EGF, 20 ng!ml; A431, 5 p1 solubi- 
lized membrane preparation from 5 x 10‘ EGF-treated A431 cells 
(UBI). B: Immunoprecipitation of EGF receptors. EGF-treated kerati- 
nocytes were lysed in RIPA buffer and equal aliquots were immuno- 
precipitated IPPT) using the anti-EGFR mAbs 528, 225, or 5-101 as 
were required to inhibit both tyrosine phosphorylation 
and TGF-a autoinduction in keratinocytes (see Discus- 
sion). 
Because agents which activate PKC can stimulate 
TGF-(r expression (Pittelkow et al., 19891, and because 
of numerous studies suggesting a link between EGF 
receptor activation, phospholipase C activation. and in- 
creased levels of the potential PKC activators calcium 
and diacylglycerol (see introduction and Discussion), 
we wished t o  determine whether PKC activation was a 
downstream signal transduction event required for 
TGF-a autoinduction. If PKC is not a downstream me- 
diator of this process, then i t  process should not be 
affected by experimental reduction of PKC activity 
4170 kDa 
- 170 kDa 
described in Materials and Methods. Primary antibody was omitted in 
the pansorbin control (Pan). Equal aliquots (10 p1/100 pl) of the solu- 
b iked  immunoprecipitates were analyzed by SDS-PAGE followed by 
immunoblotting against PY20 as described above. Equal aliquots (20 
~11250 ~ 1 )  of the 528 and 225 post-immunoprecipitation supernatants 
(SN) and pre-immunoprecipitation lysate (Pre) were run in parallel. 
A431, EGF-stimulated A431 membranes. C: lnhibition of EGF- and 
TGF-a-stimulated tyrosine phosphorylation by mAb 225 IgG. Growth 
factor-depleted keratinocytes were treated with 5 pgirnl 225 IgG for 
30 minutes, then treated for 5 minutes with the indicated concentra- 
tions of EGF or TGF-a. 225, anti-EGF receptor mAb 225 IgG: MOPC, 
isotype control mAb MOPC 21. Concentrations of EGF and TGF-a are 
given in ngiml. A431, EGF-stimulated A431 membranes. 
prior to TGF-alEGF treatment. Because of the lack of 
specificity of most protein kinase inhibitors, we chose to 
assess the PKC independence of TGF-a autoinduction 
by down-regulation of PKC activity (Tapley and Mur- 
ray, 1984). TPA is commonly used for this purpose, but 
is unsuitable for use in keratinocytes because it causes 
loss of EGF receptors in these cells (Jeng et al., 1985; 
Jetten et al., 1989) and causes a sustained induction of 
TGF-a mRNA (Pittelkow et al., 1989). Bryostatin is a 
macrocyclic lactone which causes membrane transloca- 
tion of PKC followed by down-regulation of PKC activ- 
ity (Kraft et al., 19871, with only a transient loss of EGF 
binding in keratinocytes (Sako et al., 1987; Jetten et 
al., 1989). To verify that PKC activity was reduced by 
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Fig. 3. inhibition of keratinocyte growth by anti-EGFR IgG. Keratinocytes were plated in Keratinocyte 
Basal Medium (Clonetics) containing EGF (1 ng/mli, insulin (5 pgiml), and bovine pituitary extract 
(0.4%). Twenty-four hour8 after plating, azide-free 225 IgG in phosphate buffered saline was added to each 
dish at  the indicated concentrations. Duplicate dishes were fixed and stained with crystal violet two 
weeks later. 
bryostatin, growth factor-depleted keratinocytes were 
treated with various concentrations of bryostatin for 18 
hours and PKC activity was determined. After 20 nM 
bryostatin treatment, PKC activity was reduced by an  
average of 91% (Fig. 5). Consistent with its inhibitory 
effect on PKC activity, at this dose bryostatin totally 
inhibited TPA-stimulated accumulation of TGF-a 
mRNA (Fig. 6A). Furthermore, bryostatin, unlike TPA, 
did not itself induce TGF-a mRNA (Fig. 6A). Consistent 
with the hypothesis that PKC activation is not a down- 
stream mediator of TGF-a autoinduction, accumula- 
tion of TGF-a mRNA in response to exogenous TGF-a 
was not inhibited by bryostatin treatment (Fig. 6B,C). 
Because PKC has been reported to inhibit EGF recep- 
tor tyrosine kinase activity (see introduction), we hy- 
pothesized that reduction of PKC activity by bryostatin 
would potentiate EGF receptor activation in response 
to ligand as well as TGF-a autoinduction. However, as 
shown in Figure 6H and C, pretreatment with 2 or 20 
nM bryostatin for 18 hours did not alter the dose depen- 
dence or increase the magnitude of the induction of 
TGF-a mRNA in response to exogenous TGF-a. In addi- 
tion, pretreatment with 20 nM bryostatin failed to po- 
tentiate tyrosine phosphorylation of the 170 kDa band 
on Western blots in response to 20 or 200 ngiml EGF 
(Fig. 7). 
DISCUSSION 
Several studies involving transfection of normal and 
mutant receptors have demonstrated an important role 
for the tyrosine kinase activity of the EGF receptor in 
mediating the pleiotypic response to EGF (Honegger et 
al., 1987; Chen et al., 1987; Pierce et  al., 1988). We have 
hypothesized that one component of this response, the 
autoinduction of TGF-CY mRNA and protein, could be 
relevant to the pathogenesis of psoriasis (Elder et al., 
1989a, and vide supra). However, transfection of EGF 
receptors cannot be used to assess the role of EGF re- 
ceptor tyrosine kinase activation in this process in ke- 
ratinocytes due to endogenous EGF receptor expression 
in these cells. Therefore, we have tested the specificity 
of this response for various polypeptide ligands, and 
made use of specific antibodies and inhibitors to demon- 
strate that accumulation of TGF-a mRNA in response 
to exogenous TGF-a or EGF occurs via the EGF recep- 
tor and requires its tyrosine kinase activity. In addi- 
tion, we demonstrate for the first time the pattern of 
EGF- and TGF-a-stimulated tyrosine phosphorylation 
in intact human keratinocytes, and compare this imme- 
diate (proximal) response t o  agonist to the delayed (dis- 
tal) response of TGF-w autoinduction under various 
conditions. 
EGF and TGF-a stimulate tyrosine 
phosphorylation of a 170 kDa substrate in intact 
keratinocytes 
Figure 2 demonstrates that both EGF and TGF-a 
rapidly and markedly stimulate tyrosine phosphoryla- 
tion of a 170 kDa band in detergent lysates of quiescent 
cultured keratinocytes, consistent with phosphoryla- 
tion of the EGF receptor. Three different anti-EGFR 
mAbs immunoprecipitated a band of the same Mr, iden- 
tifying this band as the EGF receptor (Fig. 2B). Back- 
ground bands of 40, 47, 84, and about 110 kDa have 
been variably noted in a number of experiments (Figs. 
1 ,4 ,  7); however, the molecular identity of these bands 
is presently unclear. Utilizing metabolic labelling cou- 
pled with immunoprecipitation, Uvir and colleagues 
(1991) have reported EGF-dependent tyrosine phospho- 
rylation of the EGF receptor as well as additional bands 
in permeabilized keratinocytes grown on fibroblast 
feeder layers. However, this is the first description of 
the pattern of EGF- and TGF-a-stimulated tyrosine 
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Fig. 4. Inhibition of EGF-stimulated tyrosine phosphorylation and 
TGF-a autoinduction by tyrphostin. A Immunoblot analysis of ty- 
rosine phosphorylation. Growth factor-depleted keratinocytes were 
treated with the indicated concentrations of RG50864 or RG50862 for 
18 hours. EGF was then added for 5 minutes at  37”C, and cells were 
lysed for immunoblot analysis as described in Materials and Methods. 
Identical results have been obtained using TGF-a rather than EGF as 
agonist (not shown). Results shown are representative of 4 indepen- 
dent experiments. B: IZNA blot analysis. Quiescent keratinocytes 
In most of our experiments, only a single 170 kDa 
band demonstrated agonist-dependent tyrosine phos- 
phorylation (Figs. 2,4). However, we have occasionally 
observed agonist-dependent phosphorylation of a band 
of about 110 kDa, the identity of which is presently 
unknown (Fig. 7). It is possible that differences in cul- 
ture conditions and/or the use of permeabilized rather 
than intact living cells may account for the differences 
between these our studies and those of Dvir et al. How- 
ever, in neither study was tyrosine phosphorylation of a 
Mr 145 kDa band observed, as  would be expected if 
PLC-gamma1 were a predominant substrate for the 
EGF receptor. Tyrosine phosphorylation of a variety of 
proteins, including but not limited t o  growth factor re- 
ceptors, has been shown to stimulate binding to other 
proteins bearing Src homology (SH) domains (Koch et 
al., 1991). Our observation that the 170 kDa band is the 
predominant protein phosphorylated on tyrosine in re- 
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tyrosine phosphorylation of substrates other than the 
EGF receptor itself may not be central to the mode of 
EGFITGF-o( action in keratinocytes. 
TGF-a autoinduction requires EGF receptor 
activation 
Of 13 polypeptide ligands tested, only EGF and 
TGF-a stimulated TGF-LU mRNA levels in quiescent 
keratinocytes (Table 11, which strongly suggests that 
TGF-a autoinduction is a specific receptor-mediated 
event. Consistent with this interpretation, autoinduc- 
tion of TGF-a mRNA (Fig. 1B,C), EGF-dependent ty- 
rosine phosphorylation (Fig. 2 0 ,  and keratinocyte 
growth (Fig. 3 )  were all markedly inhibited by the anti- 
EGF receptor monoclonal antibody, 225 IgG. The tyr- 
phostin RG50864 markedly inhibited EGF- and TGF- 
a-dependent tyrosine phosphorylation (Fig. 4A) and 
autoinduction of TGF-a mRNA (Fig. 4B,C), strongly 
suggesting that the tyrosine kinase activity of the EGF 
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Fig. 5. Down regulation of PKC by bryostatin. Growth factor-de- 
pleted keratinocytes were treated with bryostatin and PKC activity 
was determined as  described in Materials and Methods. Bars indicate 
mean ? SEM of 5 experiments (except 0.2 nM bryostatin, 4 experi- 
ments). Data are expressed as a percentage of untreated controls. 
receptor is required for this process. The dose response 
of TGF-cx mRNA accumulation (Fig. 1A) was maximal 
at 20 ngiml TGF-cx (4 nM) and ranged from 1-20 ngiml 
(0.2-4 nM), in general agreement with the saturation 
binding curve for EGF in human KC (Kd = 0.5 nM, 
saturation a t  2 nM) (Nicknloff and Mitra, 1989). These 
results suggest that high receptor occupancy is re- 
quired for autoinduction under these conditions. The 
relatively high concentrations of RG50864 required to 
inhibit autoinduction and tyrosine phosphorylation in 
these experiments (Fig. 4) could reflect this require- 
ment for high receptor occupancy, and/or the observa- 
tion that tyrphostin potency is reduced in late log 
phaselearly stationary phase human keratinocytes 
(Ferriola et al., 1991). 
Two pathways for induction of TGF-a mRNA 
Although direct activators of PKC such as  TPA and 
diacylglycerols can clearly cause accumulation of 
TGF-a mRNA (Pittelkow et al., 1989), several lines of 
evidence indicate that EGF receptor tyrosine kinase 
and PKC activation stimulate TGF-cr expression by dis- 
tinct mechanisms. Thus, TGF-a autoinduction was in- 
hibited by the tyrosine kinase inhibitor RG50864 (Fig. 
4) but not after down-regulation of over 90% of kerati- 
nocyte PKC activity in response to bryostatin (Figs. 5, 
6). In contrast, induction of TGF-a in response to TPA 
treatment was markedly inhibited by bryostatin (Fig. 
6B). It is noteworthy that unlike TPA, bryostatin did 
not stimulate TGF-a mRNA levels (Fig. 6B). This ob- 
servation is consistent with several reports demon- 
strating that bryostatins mimic only some but antago- 
nize many of the actions of TPA (Smith et al., 1985; 
Sako et al., 1987; Kraft et al., 1987; Jetten et al., 1989; 
Gschwendt et al., 1988). 
TGF-a autoinduction may not require PKC 
activation 
Based on the insensitivity of TGF-a autoinduction to 
bryostatin treatment (Fig. 6), we conclude that activa- 
tion of PKC is not necessary for TGF-ct autoinduction in 
keratinocytes. The use of other protein kinase inhibi- 
tors, such as  the isoquinolinesulfonamide H-7, is inap- 
propriate for this purpose, since these inhibitors are not 
specific for inhibition of protein kinase C (Hidaka et al., 
1984). Our results are consistent with several reports 
demonstrating that EGF does not functionally activate 
PKC in epithelial cells (Vaartjes et al., 1986; Baliga 
and Morowitz, 1988; Thompson et al., 1988). While 
modest elevations of phosphoinositide turnover and/or 
DAG mass have been observed in response t o  EGF in 
murine keratinocytes, hamster fibroblasts, A431 cells, 
and rat hepatocytes (Moscat et al., 1988; Johnson and 
Garrison, 1987; Kato et al., 1988; Pessin et al., 19901, 
activation of PKC in response to EGF has not been 
detected by direct measurement. In one study (Moscat 
et al., 1988), a modest (<twofold) increase in phosphor- 
ylation of an  acidic 80 kDa protein (MARCKS protein), 
thought to  be a specific substrate for PKC phosphoryla- 
tion (Blackshear et al., 19851, was observed in response 
to EGF in BALB/MK immortalized murine kerati- 
nocytes. However, in many cell lines, serum and/or di- 
rect PKC activators such as TPA lead to much larger 
increases in MARCKS phosphorylation (Blackshear et 
al., 1991). Moreover, we have been unable to demon- 
strate significant EGF- or TGF-a-stimulated phosphor- 
ylation of MARCKS protein in normal human kerati- 
nocytes under conditions in which large increases in 
tyrosine phosphorylation of the 170 kDa protein have 
been consistently detected (N. Reynolds, T. Jensen, J. 
Elder, and G. Fisher, manuscript in preparation). Simi- 
larly, exhaustive studies of insulin responses in cells 
massively overexpressing insulin receptors have failed 
to convincingly demonstrate PKC activation as a down- 
stream event in the cellular response t o  insulin (Black- 
shear et al., 1991). Nevertheless, i t  remains possible 
that PKC isoforms whose activity might not be detect- 
able under our assay conditions and which may not be 
down-regulated by bryostatin could be involved in the 
transduction of the autoinductive response to TGF-a. 
Bryostatin down-regulates PKC but does not 
potentiate EGF responses 
Phosphorylation of 654Thr of the EGF receptor by 
PKC results in inhibition of EGFR-TK activity, and 
mutation of this residue leads to loss of phorbol ester 
inhibition of EGF-stimulated growth (Friedman et  al., 
1984; Livneh et al., 1988; Decker et al., 1990). Loss of 
PKC-mediated inhibition of EGFR-TK could explain 
the increased TGF-a gene expression and proliferation 
which occur in the context of reduced PKC activity in 
psoriatic epidermis. However, we were unable to dem- 
onstrate potentiation of TGF-a autoinduction (Fig. 
6B,C1 or of EGF-stimulated tyrosine phosphorylation 
(Fig. 7) after down-regulation of PKC activity with bry- 
ostatin. These results, as  well as the inability of bry- 
ostatin to stimulate TGF-cx mRNA (Fig. 6A) raise the 
possibility that PKC isoforms not detectable by our as- 
say conditions and/or unresponsive to bryostatin are 
involved in down-regulation of EGF receptor tyrosine 
kinase activity in keratinocytes. 
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Pig. 6. A Hryostatin inhibits the accumulation of TGF-a mRNA by 
TPA. Growth factor-depleted keratinocytes were pretreated with 20 
nM bryostatin for either 4 or 18 hours. TPA (20 nM) or DMSO solvent 
(cont) was then added and RNA was harvested 4 hours later. There- 
fore, total time of bryostatin treatment was either 8 or 22 hours. There 
was also no effect of bryostatin alone on TGF-cr mRNA levels after 4 
hours of treatment (data not shown). TGF-u and cyclophilin tran- 
scripts were analyzed by blot hybridization. Mobilities of ribosomal 
RNAs are indicated to the left. B: TGP-u autoinduction is unaffected 
by bryostatin. Growth factor-depleted keratinocytes were pretreated 
with 0, 2, or 20 nM bryostatin for 18 hours, then treated for 4 hours 
with the indicated concentrations of TGF-cr and analyzed as described 
in Materials and Methods. Mobilities of ribosomal RNAs are indicated 
to the left. Data shown are representative of 3 experiments. C: Quan- 
titation of autoradiogram shown in Fig. 6B. Analysis was performed 
by laser densitometry as in Fig. 4C, except that values were not nor- 
malized to cyclophilin. Cyclophilin densitometric values were 
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Fig. 7. Immunohlot analysis of hryostatin effects on EGF-stimulated tyrosine phosphorylation in 
growth factor-depeleted keratinocytes. Cells were pretreated with 20 nM bryostatin for 18 hours, then 
treated for 5 minutes with the indicated concentrations of EGF. The results of 2 independent experiments 
are shown. 
Summary and perspectives 
The results presented here argue for the existence of 
at least two pathways by which TGF-a can be stimu- 
lated in human keratinocytes. TGF-a autoinduction oc- 
curs via a pathway which is triggered by activation of 
the EGF receptor tyrosine kinase in response to EGF or 
TGF-LU, and is not inhibited or potentiated by bryosta- 
tin. In contrast, induction of TGF-a by TPA occurs inde- 
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pendently of EGF receptor activation, and is inhibited 
by PKC down-regulation in response to bryostatin. I t  is 
possible that TGF-a plays important roles in both pro- 
liferation and differentiation of the epidermis, as  sug- 
gested by Finzi et al. (1991). If this is the case, the 
TGF-a autoinductive pathway may be important in the 
regulation of keratinocyte growth, while the PKC-de- 
pendent pathway of TGF-a activation may be involved 
in the regulation of keratinocyte differentiation. 
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